Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.

@article{Savoia2008SelectiveMR,
  title={Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.},
  author={Carmine Savoia and Rhian M Touyz and Farhad Abbassi Amiri and Ernesto L Schiffrin},
  journal={Hypertension},
  year={2008},
  volume={51 2},
  pages={432-9}
}
Some antihypertensive agents may improve resistance artery remodeling in hypertensive patients whereas other agents may not, for similar blood pressure reduction. We questioned whether the selective mineralocorticoid receptor blocker eplerenone improves resistance artery remodeling in hypertensive patients versus the beta-blocker atenolol. Sixteen hypertensive patients were randomly assigned to double-blind daily treatment with eplerenone or atenolol. Resistance arteries from gluteal… CONTINUE READING
64 Citations
39 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 64 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 39 references

Similar Papers

Loading similar papers…